Capital Research Global Investors Grows Stake in Molina Healthcare, Inc $MOH

Capital Research Global Investors lifted its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 0.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 795,909 shares of the company’s stock after acquiring an additional 3,123 shares during the quarter. Capital Research Global Investors’ holdings in Molina Healthcare were worth $138,122,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 217.0% during the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Molina Healthcare by 344.3% during the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after acquiring an additional 746,639 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 31.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 938,677 shares of the company’s stock worth $179,632,000 after acquiring an additional 222,346 shares during the last quarter. Norges Bank bought a new stake in shares of Molina Healthcare during the 4th quarter worth $109,766,000. Finally, UBS Group AG lifted its holdings in shares of Molina Healthcare by 320.7% during the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after acquiring an additional 460,372 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Analyst Ratings Changes

MOH has been the subject of a number of research analyst reports. Truist Financial lifted their price objective on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a report on Monday, May 11th. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a report on Wednesday, April 29th. Barclays lifted their price objective on shares of Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a report on Tuesday, May 26th. The Goldman Sachs Group dropped their price objective on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a report on Wednesday, February 11th. Finally, Zacks Research raised shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and an average price target of $182.73.

Molina Healthcare Stock Performance

Shares of NYSE:MOH opened at $198.34 on Tuesday. The company has a market cap of $10.33 billion, a price-to-earnings ratio of 58.68 and a beta of 0.80. The company has a 50-day moving average price of $169.59 and a 200-day moving average price of $162.97. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $311.52.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Activity

In related news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by insiders.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.